OR WAIT null SECS
© 2023 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Some rheumatology patients have very strong opinions about whether they should continue to take immunosuppressive drugs under the threat of coronavirus. In this interview with Rheumatology Network, Dr. Andrew Concoff, Executive Vice President and Chief Value Officer of United Rheumatology, addresses the hazards of suddenly stopping these medications.
Some rheumatology patients have very strong opinions about whether they should continue to take immunosuppressive drugs under the threat of coronavirus. In this interview with Rheumatology Network, Dr. Andrew Concoff, Executive Vice President and Chief Value Officer of United Rheumatology, addresses the hazards of suddenly stopping these medications.